Drug pricing has been a national issue for decades. The proposed tariffs are intended to push more drug manufacturing to the United States, administration officials have said.

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.

As President Trump takes aim at international price differences for drugs through his Most Favored Nation executive order, this article looks at how the differences occur and the issues they raise.

President Donald Trump recently made his boldest claim yet in his longstanding promise to lower drug prices. “You know, we’ve cut drug prices by 1,200, 1,300 and 1,400, 1,500%,” he told reporters on Sunday, noting the reductions will start over the ...

A federal website notice, deleted and then reposted by the administration, provides a hint that more aggressive pricing policies may be coming.

This week on IPWatchdog Unleashed, we have a conversation about one of the hottest topics not just in the intellectual property world, but one that people are discussing both inside and outside of government. The cost of prescription pharmaceuticals is ...

President Trump proposed a plan to lower prescription drug prices, focusing on the "Most Favored Nation" executive order. The plan aims to address the disparity in drug prices between the U.S. and other countries with price controls. Potential solutions ...

For decades, America’s drug-price debate has centered on a fundamental tension: How do policymakers encourage expensive research and development, while ensuring that companies keep final prices affordable? Studies show that companies will continue to ...